FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...